Financial Sense Advisors, Inc. Vertex Pharmaceuticals Inc Transaction History

Financial Sense Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$187.49 - $221.1 $1.81 Million - $2.13 Million	-9,641 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$207.02 - $241.31 $260,638 - $303,809	1,259 Added 15.02%	9,641 $2.07 Million
Q4 2020 Feb 03, 2021	BUY	$207.01 - $276.09 $1.74 Million - $2.31 Million	8,382 New	8,382 $1.98 Million

1,714

226M

1.21M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Financial Sense Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Sense Advisors, Inc. with notifications on news.